Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Launched by ECOG-ACRIN CANCER RESEARCH GROUP · Jul 6, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The PET-Stop Trial is a study looking at how doctors can use special tests called biomarkers from PET/CT scans to decide if patients with advanced melanoma can safely stop their anti-PD-1 treatment earlier. Anti-PD-1 therapy is a common treatment for melanoma that cannot be surgically removed. The goal of this trial is to see if these biomarkers can help identify patients who are responding well to treatment and might not need to continue for the full duration.
To be part of this trial, patients should have advanced melanoma that cannot be removed by surgery and must have been receiving anti-PD-1 therapy for about a year. They need to show positive results from their scans and meet other health criteria, such as having a certain level of blood cells. During the trial, participants will undergo scans and possibly biopsies to assess their condition. This study aims to improve treatment strategies for patients with melanoma, making it safer and more effective.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • STEP 0 PRE-REGISTRATION INCLUSION CRITERIA
- • Patient must have active advanced melanoma, defined as unresectable stage IIIB-IV by American Joint Committee on Cancer (AJCC) 8th edition
- • Patient must have melanoma originating from cutaneous, acral-lentiginous, or mucosal primary sites. Patients with melanoma of unknown primary site are eligible. Patients must not have melanoma from an ocular primary site
- • Patient must have had measurable disease by immune related Response Evaluation Criteria in Solid Tumors (imRECIST) prior to start of initial anti-PD-1 therapy
- * Patient must be actively receiving standard of care anti-PD-1 therapy, currently be 52 weeks (+/- 2 weeks) from start of anti-PD-1 therapy, and have not experienced a toxicity that prevents them from continuing on therapy. Permitted systemic anti-PD-1 therapy regimens include:
- • Nivolumab 240 mg IV every (Q)2weeks or 480 mg IV Q4weeks
- • Pembrolizumab 200 mg IV Q3weeks or 400 mg IV Q6weeks
- • Nivolumab 1 mg/kg plus ipilimumab 3 mg/kg IV Q3weeks induction x 4 doses, followed by nivolumab 240 mg IV Q2weeks or 480 mg IV Q4weeks maintenance
- • Nivolumab 3 mg/kg plus Ipilimumab 1 mg/kg IV Q3weeks induction x 4 doses, followed by nivolumab 240 mg IV Q2weeks or 480 mg IV Q4weeks maintenance
- • Pembrolizumab 2 mg/kg (or 200 mg flat dose) plus Ipilimumab 1 mg/kg IV Q3weeks induction x 4 doses, followed by pembrolizumab 200 mg IV Q3weeks or 400 mg IV Q6weeks maintenance
- • Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
- • Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial. Patients with detectable viral loads are excluded as it is unclear if these patients have a low risk of melanoma progression off anti-PD-1 treatment
- • For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated
- • Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load
- • Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
- • Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class 2B or better
- • Patient must have experienced complete response, partial response, or stable disease on restaging CT scans by imRECIST that is maintained on restaging scans obtained at week 52 (+/- 2 weeks) from start of initial anti-PD-1 therapy
- • Patient must have completed an FDG-PET/CT scan at week 52 (+/- 2 weeks) from start of initial anti-PD-1 therapy
- * Patients with PET/CT positive for hypermetabolic lesions: If a core needle, punch or excisional biopsy and pathological review of a representative lesion was not performed prior to pre-registration (Step 0) must either:
- • Be amenable to undergo a biopsy. Patient must not be on anticoagulation therapy or, if on anti-coagulation therapy, patient must be able to hold treatment for a biopsy procedure (core needle, punch or excisional biopsy). Anti-coagulation therapy is defined as low molecular weight heparin, warfarin, factor Xa inhibitor, or direct thrombin inhibitor
- • Have documentation of inability to perform the biopsy due to feasibility or safety concerns
- • Leukocytes \>= 3,000/mcL (obtained =\< 4 weeks prior to protocol registration)
- • Absolute neutrophil count \>= 1,500/mcL (obtained =\< 4 weeks prior to protocol registration)
- • Platelets \>= 100,000/mcL (obtained =\< 4 weeks prior to protocol registration)
- • Total bilirubin =\< institutional upper limit of normal (ULN) (patients with history of Gilbert's syndrome are permitted to have a total bilirubin \> 1.5 x institutional ULN) (obtained =\< 4 weeks prior to protocol registration)
- • Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase \[SGOT\])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase \[SGPT\]) =\< 2.5 x institutional ULN (obtained =\< 4 weeks prior to protocol registration)
- • Creatinine =\< 1.5 x institutional ULN (obtained =\< 4 weeks prior to protocol registration)
- • STEP 1 REGISTRATION INCLUSION CRITERIA
- • Patient met all eligibility criteria outlined above
- • Patient must register to Step 1 within 4 weeks of registration to Step 0
- * Patients must meet one of the following criteria:
- • Patient had no positive hypermetabolic lesions on the week 52 FDG-PET/CT.
- * Patients with positive hypermetabolic lesion(s) on the week 52 FDG-PET/CT (positive hypermetabolic = standard uptake volume \[SUV\] \> pooled mediastinal blood), one of the following must have occurred:
- • A representative lesion was biopsied (core needle, punch or excisional biopsy) within 14 days of registration to Step 0 and subsequent pathology review performed to determine the presence or absence of viable tumor
- • Documentation is present that the patient is not able to undergo biopsy of a hypermetabolic lesion due to feasibility or safety concerns, i.e., the lesion location that is not amenable to biopsy
- Exclusion Criteria:
- • STEP 0 PRE-REGISTRATION EXCLUSION CRITERIA
- • Patient must not be receiving concurrent anti-tumor therapies in addition to the standard of care anti-PD-1 regimens. Patients who are receiving bisphosphonates and RANKL inhibitors for management of bone metastases are eligible
- • Patient must not have brain metastases
- • Women must not be pregnant or breast-feeding due to potential harm to an unborn fetus and possible risk for adverse events in nursing infants with the anti-PD-1 regimens being used. All females of childbearing potential must have a blood test or urine study within 14 days prior to registration to rule out pregnancy. A female of childbearing potential is defined as any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
- • Women of childbearing potential and sexually active males must not conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse from the time of study registration and continuing until at least 5 months after the last dose of anti-PD-1 treatment for female patients and for at least 7 months after the last dose of anti-PD-1 treatment for male patients who are sexually active with a women of childbearing potential (WOCBP)
About Ecog Acrin Cancer Research Group
The ECOG-ACRIN Cancer Research Group is a prominent clinical trial sponsor dedicated to advancing cancer research through innovative clinical trials and rigorous scientific inquiry. As a collaborative network of researchers, healthcare professionals, and institutions, ECOG-ACRIN focuses on improving cancer treatment and patient outcomes by conducting high-quality, multicenter studies. Their research spans various cancer types and includes a wide array of therapeutic approaches, emphasizing the integration of cutting-edge methodologies and patient-centered care. Committed to fostering collaboration and sharing knowledge, ECOG-ACRIN plays a vital role in transforming cancer care and enhancing the understanding of cancer biology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Durham, North Carolina, United States
Cleveland, Ohio, United States
Milwaukee, Wisconsin, United States
Buffalo, New York, United States
Saint Louis, Missouri, United States
Flint, Michigan, United States
Denver, Colorado, United States
Denver, Colorado, United States
Lone Tree, Colorado, United States
Flint, Michigan, United States
Kalamazoo, Michigan, United States
Peoria, Illinois, United States
Little Rock, Arkansas, United States
Boston, Massachusetts, United States
Hackensack, New Jersey, United States
Oklahoma City, Oklahoma, United States
Des Moines, Iowa, United States
Great Falls, Montana, United States
New York, New York, United States
Kalamazoo, Michigan, United States
Traverse City, Michigan, United States
Kalispell, Montana, United States
Delaware, Ohio, United States
Lancaster, Ohio, United States
Sheridan, Wyoming, United States
Cincinnati, Ohio, United States
Charlottesville, Virginia, United States
Mount Vernon, Illinois, United States
Chillicothe, Ohio, United States
Urbana, Illinois, United States
Carroll, Iowa, United States
Ann Arbor, Michigan, United States
Mobile, Alabama, United States
Council Bluffs, Iowa, United States
Dayton, Ohio, United States
Effingham, Illinois, United States
Saint Joseph, Missouri, United States
Greenville, Ohio, United States
Mount Vernon, Ohio, United States
Bethlehem, Pennsylvania, United States
Wisconsin Rapids, Wisconsin, United States
Longmont, Colorado, United States
Springfield, Illinois, United States
Cincinnati, Ohio, United States
Springfield, Illinois, United States
Danville, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Salt Lake City, Utah, United States
Aurora, Colorado, United States
Tucson, Arizona, United States
Washington, District Of Columbia, United States
Atlanta, Georgia, United States
Chicago, Illinois, United States
Duluth, Minnesota, United States
Saint Cloud, Minnesota, United States
Saint Louis, Missouri, United States
Kearney, Nebraska, United States
New York, New York, United States
Chapel Hill, North Carolina, United States
Bismarck, North Dakota, United States
Fargo, North Dakota, United States
Columbus, Ohio, United States
Hershey, Pennsylvania, United States
Burlington, Vermont, United States
Aurora, Illinois, United States
Neptune, New Jersey, United States
Columbus, Ohio, United States
Columbus, Ohio, United States
Kettering, Ohio, United States
Allentown, Pennsylvania, United States
Federal Way, Washington, United States
Lakewood, Washington, United States
Wyoming, Michigan, United States
Cape Girardeau, Missouri, United States
Elmhurst, Illinois, United States
Washington, District Of Columbia, United States
Denver, Colorado, United States
Englewood, Colorado, United States
Pueblo, Colorado, United States
Saint Louis, Missouri, United States
Omaha, Nebraska, United States
Lima, Ohio, United States
Berlin, Vermont, United States
Omaha, Nebraska, United States
Glens Falls, New York, United States
Fort Lauderdale, Florida, United States
Grand Rapids, Michigan, United States
Oakland, California, United States
Miami, Florida, United States
Sioux Falls, South Dakota, United States
Detroit, Michigan, United States
Saint Louis, Missouri, United States
Marshfield, Wisconsin, United States
Newark, Ohio, United States
Decatur, Illinois, United States
Ottawa, Illinois, United States
Peoria, Illinois, United States
Galesburg, Illinois, United States
Clive, Iowa, United States
Des Moines, Iowa, United States
Des Moines, Iowa, United States
Des Moines, Iowa, United States
Lansing, Michigan, United States
Warren, Michigan, United States
Brainerd, Minnesota, United States
Duluth, Minnesota, United States
Duluth, Minnesota, United States
Lincoln, Nebraska, United States
Papillion, Nebraska, United States
Omaha, Nebraska, United States
Los Angeles, California, United States
Reed City, Michigan, United States
Cape Girardeau, Missouri, United States
Peru, Illinois, United States
Des Moines, Iowa, United States
Adrian, Michigan, United States
Monroe, Michigan, United States
Pontiac, Michigan, United States
Findlay, Ohio, United States
Maumee, Ohio, United States
Toledo, Ohio, United States
Toledo, Ohio, United States
Hazleton, Pennsylvania, United States
Wilkes Barre, Pennsylvania, United States
Spartanburg, South Carolina, United States
Kalamazoo, Michigan, United States
Scranton, Pennsylvania, United States
Bremerton, Washington, United States
Atlanta, Georgia, United States
Rohnert Park, California, United States
Sacramento, California, United States
Fremont, California, United States
Richmond, California, United States
Roseville, California, United States
Sacramento, California, United States
San Francisco, California, United States
San Jose, California, United States
San Leandro, California, United States
Santa Clara, California, United States
Santa Rosa, California, United States
South San Francisco, California, United States
Stockton, California, United States
Vallejo, California, United States
Walnut Creek, California, United States
Lawrenceville, Georgia, United States
Alton, Illinois, United States
Galesburg, Illinois, United States
Richmond, Indiana, United States
Ames, Iowa, United States
Baltimore, Maryland, United States
Battle Creek, Michigan, United States
Grand Rapids, Michigan, United States
Grand Rapids, Michigan, United States
Muskegon, Michigan, United States
Saginaw, Michigan, United States
Saint Joseph, Michigan, United States
Bemidji, Minnesota, United States
Joplin, Missouri, United States
Springfield, Missouri, United States
Springfield, Missouri, United States
Billings, Montana, United States
Red Bank, New Jersey, United States
Boardman, Ohio, United States
Cincinnati, Ohio, United States
Dayton, Ohio, United States
Franklin, Ohio, United States
Toledo, Ohio, United States
Troy, Ohio, United States
Warren, Ohio, United States
Youngstown, Ohio, United States
East Stroudsburg, Pennsylvania, United States
Sioux Falls, South Dakota, United States
Burlington, Vermont, United States
Tacoma, Washington, United States
Minocqua, Wisconsin, United States
Oconomowoc, Wisconsin, United States
Rice Lake, Wisconsin, United States
Waukesha, Wisconsin, United States
Wausau, Wisconsin, United States
Weston, Wisconsin, United States
Greenville, North Carolina, United States
Kettering, Ohio, United States
Aurora, Colorado, United States
Colorado Springs, Colorado, United States
Lakewood, Colorado, United States
Savannah, Georgia, United States
Naperville, Illinois, United States
Columbus, Ohio, United States
Columbus, Ohio, United States
Marietta, Ohio, United States
Newark, Ohio, United States
Springfield, Ohio, United States
Westerville, Ohio, United States
Zanesville, Ohio, United States
Livonia, Michigan, United States
Mansfield, Ohio, United States
Bremerton, Washington, United States
Littleton, Colorado, United States
Albuquerque, New Mexico, United States
Denver, Colorado, United States
Denver, Colorado, United States
Tucson, Arizona, United States
Saint Joseph, Michigan, United States
Fairhope, Alabama, United States
Honolulu, Hawaii, United States
Louisville, Kentucky, United States
Chippewa Falls, Wisconsin, United States
Canton, Illinois, United States
Carthage, Illinois, United States
Eureka, Illinois, United States
Kewanee, Illinois, United States
Macomb, Illinois, United States
Peru, Illinois, United States
Princeton, Illinois, United States
Boise, Idaho, United States
Fargo, North Dakota, United States
Parker, Colorado, United States
Niles, Michigan, United States
Joplin, Missouri, United States
Grand Island, Nebraska, United States
Fort Smith, Arkansas, United States
Post Falls, Idaho, United States
Bloomington, Illinois, United States
Pekin, Illinois, United States
Fergus Falls, Minnesota, United States
Bolivar, Missouri, United States
Branson, Missouri, United States
Saint Louis, Missouri, United States
Raleigh, North Carolina, United States
Poulsbo, Washington, United States
Carmichael, California, United States
Raleigh, North Carolina, United States
Fairbanks, Alaska, United States
Hot Springs, Arkansas, United States
Vacaville, California, United States
Denver, Colorado, United States
Lafayette, Colorado, United States
Jefferson City, Missouri, United States
Saint Louis, Missouri, United States
Omaha, Nebraska, United States
Oklahoma City, Oklahoma, United States
Bryan, Texas, United States
Antioch, California, United States
Fresno, California, United States
Modesto, California, United States
Oakland, California, United States
Rancho Cordova, California, United States
Roseville, California, United States
South San Francisco, California, United States
West Des Moines, Iowa, United States
Rolla, Missouri, United States
Rolla, Missouri, United States
Fargo, North Dakota, United States
Beachwood, Ohio, United States
Columbus, Ohio, United States
Columbus, Ohio, United States
Portsmouth, Ohio, United States
Sandusky, Ohio, United States
Burien, Washington, United States
Urbana, Illinois, United States
Springfield, Illinois, United States
Belpre, Ohio, United States
Columbus, Ohio, United States
Delaware, Ohio, United States
Longmont, Colorado, United States
Springfield, Ohio, United States
Saint Peters, Missouri, United States
Great Falls, Montana, United States
Caldwell, Idaho, United States
Coeur D'alene, Idaho, United States
Emmett, Idaho, United States
Meridian, Idaho, United States
Clive, Iowa, United States
West Des Moines, Iowa, United States
Garden City, Kansas, United States
Great Bend, Kansas, United States
Brighton, Michigan, United States
Canton, Michigan, United States
Caro, Michigan, United States
Chelsea, Michigan, United States
Clarkston, Michigan, United States
Clarkston, Michigan, United States
East China Township, Michigan, United States
Flint, Michigan, United States
Flint, Michigan, United States
Grosse Pointe Woods, Michigan, United States
Grosse Pointe Woods, Michigan, United States
Grosse Pointe Woods, Michigan, United States
Livonia, Michigan, United States
Macomb, Michigan, United States
Macomb, Michigan, United States
Marlette, Michigan, United States
Pontiac, Michigan, United States
Pontiac, Michigan, United States
Pontiac, Michigan, United States
Rochester Hills, Michigan, United States
Saginaw, Michigan, United States
Sterling Heights, Michigan, United States
Warren, Michigan, United States
Warren, Michigan, United States
Warren, Michigan, United States
Warren, Michigan, United States
West Branch, Michigan, United States
Ypsilanti, Michigan, United States
Anaconda, Montana, United States
Centerville, Ohio, United States
Dublin, Ohio, United States
Grove City, Ohio, United States
Marion, Ohio, United States
West Chester, Ohio, United States
Lewisburg, Pennsylvania, United States
Cody, Wyoming, United States
Colorado Springs, Colorado, United States
Durango, Colorado, United States
Durango, Colorado, United States
Lakewood, Colorado, United States
Thornton, Colorado, United States
Creston, Iowa, United States
Bardstown, Kentucky, United States
Corbin, Kentucky, United States
Lexington, Kentucky, United States
Lexington, Kentucky, United States
Louisville, Kentucky, United States
Shepherdsville, Kentucky, United States
Commack, New York, United States
Cincinnati, Ohio, United States
Cincinnati, Ohio, United States
Enumclaw, Washington, United States
Tacoma, Washington, United States
Boulder, Colorado, United States
Denver, Colorado, United States
Englewood, Colorado, United States
Littleton, Colorado, United States
Lone Tree, Colorado, United States
Carbondale, Illinois, United States
Carterville, Illinois, United States
Centralia, Illinois, United States
Danville, Illinois, United States
Decatur, Illinois, United States
Effingham, Illinois, United States
Mattoon, Illinois, United States
O'fallon, Illinois, United States
Swansea, Illinois, United States
Yorkville, Illinois, United States
Louisville, Kentucky, United States
Brighton, Michigan, United States
Canton, Michigan, United States
Chelsea, Michigan, United States
Ypsilanti, Michigan, United States
Sainte Genevieve, Missouri, United States
Sullivan, Missouri, United States
Sunset Hills, Missouri, United States
Centerville, Ohio, United States
Cincinnati, Ohio, United States
Dayton, Ohio, United States
Findlay, Ohio, United States
Findlay, Ohio, United States
Franklin, Ohio, United States
Greenville, Ohio, United States
Troy, Ohio, United States
Cheyenne, Wyoming, United States
Montvale, New Jersey, United States
Harrison, New York, United States
Uniondale, New York, United States
Middletown, New Jersey, United States
Lone Tree, Colorado, United States
Ames, Iowa, United States
Boone, Iowa, United States
Fort Dodge, Iowa, United States
Jefferson, Iowa, United States
Marshalltown, Iowa, United States
Pottsville, Pennsylvania, United States
Basking Ridge, New Jersey, United States
Dublin, California, United States
Fresno, California, United States
Sacramento, California, United States
San Rafael, California, United States
Norton Shores, Michigan, United States
Creve Coeur, Missouri, United States
Saint Louis, Missouri, United States
Gaffney, South Carolina, United States
Greer, South Carolina, United States
Union, South Carolina, United States
Eau Claire, Wisconsin, United States
Ladysmith, Wisconsin, United States
London, Kentucky, United States
Port Townsend, Washington, United States
Mukwonago, Wisconsin, United States
Waukesha, Wisconsin, United States
Des Moines, Iowa, United States
Ashland, Wisconsin, United States
Gahanna, Ohio, United States
Coral Gables, Florida, United States
Deerfield Beach, Florida, United States
Plainfield, Illinois, United States
Phoenix, Arizona, United States
Elk Grove, California, United States
Rocklin, California, United States
Sacramento, California, United States
San Luis Obispo, California, United States
Santa Maria, California, United States
Woodland, California, United States
Boulder, Colorado, United States
Tawas City, Michigan, United States
Perrysburg, Ohio, United States
Willow Grove, Pennsylvania, United States
Miami, Florida, United States
Beavercreek, Ohio, United States
Stevens Point, Wisconsin, United States
Los Angeles, California, United States
Arroyo Grande, California, United States
Aitkin, Minnesota, United States
Deer River, Minnesota, United States
Hibbing, Minnesota, United States
Sandstone, Minnesota, United States
Virginia, Minnesota, United States
Hazleton, Pennsylvania, United States
Ashland, Wisconsin, United States
Ballwin, Missouri, United States
Washington, Missouri, United States
Denver, Colorado, United States
Plantation, Florida, United States
Fort Dodge, Iowa, United States
Worthington, Minnesota, United States
Lake Forest, Illinois, United States
Detroit Lakes, Minnesota, United States
Fosston, Minnesota, United States
Park Rapids, Minnesota, United States
Jamestown, North Dakota, United States
Fargo, North Dakota, United States
Centennial, Colorado, United States
Denver, Colorado, United States
Englewood, Colorado, United States
Dixon, Illinois, United States
Washington, Illinois, United States
Farmington, Missouri, United States
Redwood City, California, United States
Colorado Springs, Colorado, United States
Englewood, Colorado, United States
Aventura, Florida, United States
Bozeman, Montana, United States
Duluth, Georgia, United States
Kalamazoo, Michigan, United States
Baxter, Minnesota, United States
Ely, Minnesota, United States
International Falls, Minnesota, United States
Moose Lake, Minnesota, United States
Thief River Falls, Minnesota, United States
Dublin, Ohio, United States
Spartanburg, South Carolina, United States
Spartanburg, South Carolina, United States
Cary, North Carolina, United States
Missoula, Montana, United States
Little Rock, Arkansas, United States
Hayward, Wisconsin, United States
Spooner, Wisconsin, United States
Superior, Wisconsin, United States
Fargo, North Dakota, United States
Fargo, North Dakota, United States
Grand Island, Nebraska, United States
Toledo, Ohio, United States
Toledo, Ohio, United States
Lexington, Kentucky, United States
Avon, Ohio, United States
Des Moines, Iowa, United States
Mount Sterling, Kentucky, United States
Wyoming, Michigan, United States
Grand Rapids, Michigan, United States
Muskegon, Michigan, United States
Troy, Ohio, United States
Nampa, Idaho, United States
Grove City, Ohio, United States
Pontiac, Michigan, United States
Ann Arbor, Michigan, United States
Brighton, Michigan, United States
Canton, Michigan, United States
Chelsea, Michigan, United States
Centralia, Illinois, United States
Paducah, Kentucky, United States
Danville, Illinois, United States
New Albany, Ohio, United States
Greenville, Ohio, United States
Boone, Iowa, United States
Fort Dodge, Iowa, United States
Jefferson, Iowa, United States
Marshalltown, Iowa, United States
Ames, Iowa, United States
Merced, California, United States
Ladysmith, Wisconsin, United States
Osage Beach, Missouri, United States
Ankeny, Iowa, United States
Sunset Hills, Missouri, United States
Marysville, Ohio, United States
Niles, Michigan, United States
Reed City, Michigan, United States
Saint Joseph, Michigan, United States
O'fallon, Illinois, United States
Des Moines, Iowa, United States
Clive, Iowa, United States
Lansing, Michigan, United States
Carmichael, California, United States
Grand Rapids, Michigan, United States
Saint Joseph, Michigan, United States
Jefferson City, Missouri, United States
Pontiac, Michigan, United States
Wilmington, Ohio, United States
Silverdale, Washington, United States
Dayton, Ohio, United States
Dayton, Ohio, United States
Grand Rapids, Michigan, United States
Sandpoint, Idaho, United States
Baker City, Oregon, United States
Ontario, Oregon, United States
Walnut Creek, California, United States
Patients applied
Trial Officials
Geoffrey T Gibney
Principal Investigator
ECOG-ACRIN Cancer Research Group
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials